Clarius Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,018,294
-0.9%
9,997
-1.8%
0.10%
+22.8%
Q2 2023$1,027,466
+15.0%
10,182
+4.9%
0.08%
+3.9%
Q1 2023$893,228
+92558.5%
9,709
-8.6%
0.08%
-12.6%
Q4 2022$964
-99.9%
10,621
+23.8%
0.09%
+33.8%
Q3 2022$652,000
-15.3%
8,582
-5.7%
0.06%
-15.6%
Q2 2022$770,000
+54.3%
9,104
+59.7%
0.08%
+97.4%
Q1 2022$499,0000.0%5,7000.0%0.04%0.0%
Q4 2021$499,000
+11.1%
5,700
+3.7%
0.04%
-2.5%
Q3 2021$449,000
-18.7%
5,495
-9.2%
0.04%
-20.0%
Q2 2021$552,000
+17.2%
6,050
+9.9%
0.05%
+8.7%
Q1 2021$471,000
-11.8%
5,507
-2.6%
0.05%
-20.7%
Q4 2020$534,000
+10.6%
5,653
+1.8%
0.06%
-6.5%
Q3 2020$483,000
-6.6%
5,551
-6.2%
0.06%
-13.9%
Q2 2020$517,000
+5.7%
5,919
-0.1%
0.07%
-21.7%
Q1 2020$489,000
-20.4%
5,926
-8.7%
0.09%
-5.2%
Q4 2019$614,000
-6.3%
6,489
-14.0%
0.10%
-19.2%
Q3 2019$655,000
+9.0%
7,543
+14.6%
0.12%
-0.8%
Q2 2019$601,000
+36.3%
6,583
+43.4%
0.12%
+13.1%
Q1 2019$441,000
+92.6%
4,590
+71.9%
0.11%
+28.9%
Q4 2018$229,000
-1.7%
2,670
-4.5%
0.08%
-13.5%
Q2 2017$233,000
+8.4%
2,795
-3.5%
0.10%
+7.9%
Q1 2017$215,000
-2.3%
2,895
-4.2%
0.09%
-4.3%
Q4 2016$220,000
-1.3%
3,023
+6.6%
0.09%
-10.6%
Q3 2016$223,000
-4.3%
2,835
+0.6%
0.10%
-16.1%
Q2 2016$233,0002,8170.12%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders